• Explore /
  • Poster
  • / Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

Abstract Poster

Authors

null

Robert W. Chen

City of Hope Comprehensive Cancer Center, Duarte, CA

Robert W. Chen , Stephen Maxted Ansell , Pier Luigi Zinzani , Jeffrey L. Vacirca , Armando Lopez-Guillermo , Martin Hutchings , Wojciech Jurczak , Georg Hess , Steven Le Gouill , Fritz Offner , Armando Santoro , Gilles A. Salles , Daria Stypinski , Douglas Laird , Dmitri Pavlov , Giovanna Andreola , Kolette D. Fly , Adrian Woolfson , Graham P Collins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT02951156

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS7575)

DOI

10.1200/JCO.2017.35.15_suppl.TPS7575

Abstract #

TPS7575

Poster Bd #

332b

Abstract Disclosures

Similar Posters

First Author: Catherine Thieblemont

First Author: Jason Westin

First Author: Matthew J. Matasar

First Author: Joshua Brody